HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

degrasyn

a JAK2 kinase inhibitor that induces rapid degradation of c-Myc protein in MM-1 multiple myeloma and other tumor cell lines; structure in first source
Also Known As:
2-cyano-N-(1-phenylbutyl)-3-(6-bromopyridin-2-yl)acrylamide; WP1130
Networked: 28 relevant articles (3 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Donato, Nicholas J: 8 articles (06/2015 - 04/2007)
2. Showalter, Hollis D: 5 articles (06/2015 - 12/2011)
3. Talpaz, Moshe: 5 articles (06/2015 - 04/2007)
4. Kapuria, Vaibhav: 4 articles (02/2014 - 04/2007)
5. Zheng, Xiaoxiao: 3 articles (11/2018 - 06/2015)
6. Priebe, Waldemar: 3 articles (01/2014 - 04/2007)
7. Wobus, Christiane E: 3 articles (01/2014 - 12/2011)
8. Gao, Shenmeng: 2 articles (01/2020 - 01/2020)
9. Li, Haiying: 2 articles (01/2020 - 01/2020)
10. Zhou, Bin: 2 articles (01/2020 - 01/2020)

Related Diseases

1. Neoplasms (Cancer)
2. Blast Crisis (Blast Phase)
3. Breast Neoplasms (Breast Cancer)
4. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
5. Renal Cell Carcinoma (Grawitz Tumor)

Related Drugs and Biologics

1. 2,6-diaminopyridine-3,5-bis(thiocyanate)
2. Deubiquitinating Enzymes
3. Janus Kinases
4. TNF-Related Apoptosis-Inducing Ligand
5. Proteins (Proteins, Gene)
6. Cisplatin (Platino)
7. degrasyn
8. Ubiquitin-Specific Proteases
9. Inflammasomes
10. Small Interfering RNA (siRNA)

Related Therapies and Procedures

1. Therapeutics
2. Heterologous Transplantation (Xenotransplantation)
3. Drug Therapy (Chemotherapy)